{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:46:12Z","timestamp":1791963972801,"version":"4.3.4"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Thyroid carcinomas with mutations in the\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    gene have been described rarely. Here, we report a unique thyroid carcinoma that has somatic mutations in\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    , follicular and melanocytic differentiation and distinct morphologic features, supported by a comprehensive molecular-genetic analyses. No other known pathogenic driver mutations were identified. The\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    mutations are predicted to be truncating and result in constitutive activation of mammalian target of rapamycin (mTOR) signaling that was confirmed by transcriptome expression profiling. This is the first demonstration of a thyroid follicular tumor with melanocytic differentiation and corresponding Melan-A expression may be a biomarker for this thyroid cancer. Its diffuse papillary architecture, macronuclei, multinuclear aggregates and intratumoral T lymphocytes are morphologic features not yet described in other\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    -mutated thyroid carcinomas. Morphologic overlap with classic thyroid papillary carcinoma and known technical difficulties in sequencing the large\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    gene make it likely that\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    -mutated thyroid carcinomas have been underdiagnosed so far. We suggest that\n                    <jats:italic toggle=\"yes\">TSC2<\/jats:italic>\n                    -mutated thyroid carcinoma should be considered in the differential diagnosis of any thyroid tumor that has unusual morphologic and immunohistochemical features or lacks known driver mutations in thyroid cancer.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002608","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:00:19Z","timestamp":1788336019000},"page":"1398-1405","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Unique Thyroid Carcinoma With Somatic Inactivating TSC2 Mutations, Follicular and Melanocytic Differentiation and Distinct Morphologic Features"],"prefix":"10.1097","volume":"50","author":[{"given":"Chatchanan","family":"Ausavarungnirun","sequence":"first","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Usama","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ngov","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami U.","family":"Badami","sequence":"additional","affiliation":[{"name":"Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Karcioglu","sequence":"additional","affiliation":[{"name":"Surgery, Endeavor Health System and the University of Chicago Pritzker School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd G.","family":"Kroll","sequence":"additional","affiliation":[{"name":"Departments of Pathology and Laboratory Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"R1-20261014","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"R3-20261014","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.pas.0000176432.73455.1b","article-title":"Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas","volume":"30","author":"Adeniran","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R4-20261014","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","article-title":"Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis","volume":"24","author":"Giordano","year":"2005","journal-title":"Oncogene"},{"key":"R5-20261014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/328170a0","article-title":"A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases","volume":"328","author":"Fusco","year":"1987","journal-title":"Nature"},{"key":"R6-20261014","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0092-8674(90)90659-3","article-title":"PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas","volume":"60","author":"Grieco","year":"1990","journal-title":"Cell"},{"key":"R7-20261014","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/jnci\/95.8.625","article-title":"BRAF mutation in papillary thyroid carcinoma","volume":"95","author":"Cohen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R8-20261014","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1210\/jc.2003-030838","article-title":"BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-20261014","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res"},{"key":"R10-20261014","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/modpathol.2010.112","article-title":"Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns","volume":"23","author":"Rivera","year":"2010","journal-title":"Mod Pathol"},{"key":"R11-20261014","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.289.5483.1357","article-title":"PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected]","volume":"289","author":"Kroll","year":"2000","journal-title":"Science"},{"key":"R12-20261014","doi-asserted-by":"crossref","first-page":"7156","DOI":"10.1158\/0008-5472.CAN-08-1085","article-title":"CREB3L2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis","volume":"68","author":"Lui","year":"2008","journal-title":"Cancer Res"},{"key":"R13-20261014","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/his.13401","article-title":"Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma","volume":"72","author":"Kim","year":"2018","journal-title":"Histopathology"},{"key":"R14-20261014","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0002-9440(10)63902-8","article-title":"Genetic and biological subgroups of low-stage follicular thyroid cancer","volume":"162","author":"French","year":"2003","journal-title":"Am J Pathol"},{"key":"R15-20261014","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamaoncol.2016.0386","article-title":"Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors","volume":"2","author":"Nikiforov","year":"2016","journal-title":"JAMA Oncol"},{"key":"R16-20261014","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2002-021186","article-title":"Specific pattern of RAS oncogene mutations in follicular thyroid tumors","volume":"88","author":"Vasko","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20261014","first-page":"159","article-title":"High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis","volume":"4","author":"Lemoine","year":"1989","journal-title":"Oncogene"},{"key":"R18-20261014","first-page":"403","article-title":"Detection of activated ras oncogenes in human thyroid carcinomas","volume":"2","author":"Suarez","year":"1988","journal-title":"Oncogene"},{"key":"R19-20261014","first-page":"1457","article-title":"High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma","volume":"4","author":"Bongarzone","year":"1989","journal-title":"Oncogene"},{"key":"R20-20261014","first-page":"223","article-title":"RET\/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features","volume":"4","author":"Bongarzone","year":"1998","journal-title":"Clin Cancer Res"},{"key":"R21-20261014","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.0703056104","article-title":"Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors","volume":"104","author":"Gasparre","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R22-20261014","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1158\/0008-5472.CAN-06-0171","article-title":"Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III","volume":"66","author":"Bonora","year":"2006","journal-title":"Cancer Res"},{"key":"R23-20261014","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/hupa.2000.8444","article-title":"Interphase cytogenetics in oncocytic adenomas and carcinomas of the thyroid gland","volume":"31","author":"Mazzucchelli","year":"2000","journal-title":"Hum Pathol"},{"key":"R24-20261014","doi-asserted-by":"crossref","first-page":"e38287","DOI":"10.1371\/journal.pone.0038287","article-title":"Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma","volume":"7","author":"Corver","year":"2012","journal-title":"PLoS One"},{"key":"R25-20261014","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00000478-200107000-00009","article-title":"Analysis of Hurthle cell neoplasms of the thyroid by interphase fluorescence in situ hybridization","volume":"25","author":"Erickson","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R26-20261014","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ccell.2018.06.013","article-title":"Widespread chromosomal losses and mitochondrial DNA alterations as genetic drivers in hurthle cell carcinoma","volume":"34","author":"Gopal","year":"2018","journal-title":"Cancer Cell"},{"key":"R27-20261014","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0002-9440(10)64821-3","article-title":"Molecular evidence for multicentric development of thyroid carcinomas in patients with familial adenomatous polyposis","volume":"157","author":"Miyaki","year":"2000","journal-title":"Am J Pathol"},{"key":"R28-20261014","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.humpath.2018.01.006","article-title":"Characteristics of cribriform morular variant of papillary thyroid carcinoma in post-Chernobyl affected region","volume":"74","author":"Lam","year":"2018","journal-title":"Hum Pathol"},{"key":"R29-20261014","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","article-title":"Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT\/beta-catenin pathway","volume":"31","author":"Cameselle-Teijeiro","year":"2018","journal-title":"Mod Pathol"},{"key":"R30-20261014","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12022-021-09683-0","article-title":"Cribriform-morular thyroid carcinoma is a distinct thyroid malignancy of uncertain cytogenesis","volume":"32","author":"Boyraz","year":"2021","journal-title":"Endocr Pathol"},{"key":"R31-20261014","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12105-021-01386-6","article-title":"Secretory carcinoma of the thyroid in a 49-year-old man treated with larotrectinib: protracted clinical course of disease despite the high-grade histologic features","volume":"16","author":"Saliba","year":"2022","journal-title":"Head Neck Pathol"},{"key":"R32-20261014","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2016.115","article-title":"Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion","volume":"29","author":"Dogan","year":"2016","journal-title":"Mod Pathol"},{"key":"R33-20261014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/thy.2018.0791","article-title":"GLIS rearrangement is a genomic hallmark of hyalinizing trabecular tumor of the thyroid gland","volume":"29","author":"Nikiforova","year":"2019","journal-title":"Thyroid"},{"key":"R34-20261014","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41379-019-0313-x","article-title":"PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid","volume":"32","author":"Marchio","year":"2019","journal-title":"Mod Pathol"},{"key":"R35-20261014","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.3747\/co.24.3555","article-title":"Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion-a case report","volume":"24","author":"Flader","year":"2017","journal-title":"Curr Oncol"},{"key":"R36-20261014","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00428-025-04380-3","article-title":"Chromophobe thyroid carcinoma: a distinct entity associated with TSC gene alterations","volume":"488","author":"Harahap","year":"2026","journal-title":"Virchows Arch"},{"key":"R37-20261014","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1507\/endocrj.EJ17-0096","article-title":"Chromophobe renal cell carcinoma-like thyroid carcinoma: a novel clinicopathologic entity possibly associated with tuberous sclerosis complex","volume":"64","author":"Hirokawa","year":"2017","journal-title":"Endocr J"},{"key":"R38-20261014","first-page":"1095","article-title":"Chromophobe renal cell carcinoma-like thyroid carcinoma: possible misdiagnosis as metastatic renal cell carcinoma","volume":"14","author":"Kwon","year":"2021","journal-title":"Int J Clin Exp Pathol"},{"key":"R39-20261014","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","year":"1993","journal-title":"Cell"},{"key":"R40-20261014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2009.05.011","article-title":"Perivascular epithelioid cell neoplasms: pathology and pathogenesis","volume":"41","author":"Folpe","year":"2010","journal-title":"Hum Pathol"},{"key":"R41-20261014","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/302381","article-title":"Comprehensive mutation analysis of TSC1 and TSC2-and phenotypic correlations in 150 families with tuberous sclerosis","volume":"64","author":"Jones","year":"1999","journal-title":"Am J Hum Genet"},{"key":"R42-20261014","first-page":"1802","article-title":"Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas","volume":"49","author":"Yoshida","year":"1989","journal-title":"Cancer Res"},{"key":"R43-20261014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000478-199801000-00007","article-title":"Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R44-20261014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-1759(96)00211-6","article-title":"Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1","volume":"202","author":"Kawakami","year":"1997","journal-title":"J Immunol Methods"},{"key":"R45-20261014","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1074\/jbc.M413692200","article-title":"MART-1 is required for the function of the melanosomal matrix protein PMEL17\/GP100 and the maturation of melanosomes","volume":"280","author":"Hoashi","year":"2005","journal-title":"J Biol Chem"},{"key":"R46-20261014","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1158\/1078-0432.CCR-08-1183","article-title":"Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry","volume":"15","author":"Komai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R47-20261014","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/path.4158","article-title":"Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein","volume":"229","author":"Kobos","year":"2013","journal-title":"J Pathol"},{"key":"R48-20261014","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/hmg\/ddg178","article-title":"Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution","volume":"12","author":"Kuiper","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R49-20261014","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/PAS.0000000000000720","article-title":"TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity","volume":"40","author":"Argani","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R50-20261014","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/modpathol.2017.99","article-title":"Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays","volume":"31","author":"Skala","year":"2018","journal-title":"Mod Pathol"},{"key":"R51-20261014","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s41379-021-00803-z","article-title":"TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma","volume":"34","author":"Wang","year":"2021","journal-title":"Mod Pathol"},{"key":"R52-20261014","doi-asserted-by":"crossref","first-page":"100873","DOI":"10.1016\/j.modpat.2025.100873","article-title":"TRIM63 overexpression in FISH-negative MiTF family altered renal cell carcinoma (MiTF RCC)","volume":"38","author":"Mannan","year":"2025","journal-title":"Mod Pathol"},{"key":"R53-20261014","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"R54-20261014","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/1878-0261.13421","article-title":"LIM domain-containing protein Ajuba inhibits chemotherapy-induced apoptosis by negatively regulating p53 stability in colorectal cancer cells","volume":"17","author":"Xu","year":"2023","journal-title":"Mol Oncol"},{"key":"R55-20261014","doi-asserted-by":"crossref","first-page":"111485","DOI":"10.1016\/j.mce.2021.111485","article-title":"Ajuba functions as a co-activator of C\/EBPbeta to induce expression of PPARgamma and C\/EBPalpha during adipogenesis","volume":"539","author":"Yan","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"R56-20261014","doi-asserted-by":"crossref","first-page":"104546","DOI":"10.1016\/j.phrs.2019.104546","article-title":"Ajuba: an emerging signal transducer in oncogenesis","volume":"151","author":"Jia","year":"2020","journal-title":"Pharmacol Res"},{"key":"R57-20261014","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1002\/dc.25048","article-title":"Melanotic medullary thyroid carcinoma: a case report with review of the literature","volume":"51","author":"Brzezinska","year":"2023","journal-title":"Diagn Cytopathol"},{"key":"R58-20261014","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijscr.2016.01.029","article-title":"Malignant melanoma arising in melanin-producing medullary thyroid carcinoma","volume":"20","author":"Hirokawa","year":"2016","journal-title":"Int J Surg Case Rep"},{"key":"R59-20261014","first-page":"e50310","article-title":"An aggressive form of medullary thyroid carcinoma-melanocytic subtype: a case report","volume":"15","author":"Trivedi","year":"2023","journal-title":"Cureus"},{"key":"R60-20261014","doi-asserted-by":"crossref","first-page":"e181575","DOI":"10.1172\/JCI181575","article-title":"Inhibiting the MNK1\/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses","volume":"134","author":"Huang","year":"2024","journal-title":"J Clin Invest"},{"key":"R61-20261014","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1172\/JCI128287","article-title":"mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT\/TFE regulation","volume":"129","author":"Asrani","year":"2019","journal-title":"J Clin Invest"},{"key":"R62-20261014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/path.5875","article-title":"GPNMB expression identifies TSC1\/2\/mTOR-associated and MiT family translocation-driven renal neoplasms","volume":"257","author":"Salles","year":"2022","journal-title":"J Pathol"},{"key":"R63-20261014","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/PAS.0000000000001111","article-title":"Eosinophilic solid and cystic (ESC) renal cell carcinomas harbor TSC mutations: molecular analysis supports an expanding clinicopathologic spectrum","volume":"42","author":"Palsgrove","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R64-20261014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.05.023","article-title":"Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases","volume":"80","author":"Tretiakova","year":"2018","journal-title":"Hum Pathol"},{"key":"R65-20261014","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s42003-022-04097-y","article-title":"Dual roles of mTORC1-dependent activation of the ubiquitin-proteasome system in muscle proteostasis","volume":"5","author":"Kaiser","year":"2022","journal-title":"Commun Biol"},{"key":"R66-20261014","doi-asserted-by":"crossref","first-page":"105862","DOI":"10.1016\/j.humpath.2025.105862","article-title":"Diagnostic accuracy of TRIM63 RNA-ISH in MiTF-rearranged renal cell carcinomas: results from a 331-tumor validation cohort","volume":"161","author":"Lee","year":"2025","journal-title":"Hum Pathol"},{"key":"R67-20261014","doi-asserted-by":"crossref","first-page":"e12943","DOI":"10.1111\/acel.12943","article-title":"mTORC1 underlies age-related muscle fiber damage and loss by inducing oxidative stress and catabolism","volume":"18","author":"Tang","year":"2019","journal-title":"Aging Cell"},{"key":"R68-20261014","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/PAS.0000000000002117","article-title":"Positive GPNMB immunostaining differentiates renal cell carcinoma with fibromyomatous stroma associated with TSC1\/2\/MTOR alterations from others","volume":"47","author":"Li","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R69-20261014","first-page":"368","article-title":"Tuberous sclerosis complex: new insights into pathogenesis and therapeutic breakthroughs","volume":"15","author":"Jurca","year":"2025","journal-title":"Life (Basel)"},{"key":"R70-20261014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-2-45","article-title":"Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy","volume":"2","author":"Yuan","year":"2009","journal-title":"J Hematol Oncol"},{"key":"R71-20261014","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"R72-20261014","doi-asserted-by":"crossref","first-page":"1415258","DOI":"10.3389\/fcell.2024.1415258","article-title":"Uncovering hidden genetic variations: long-read sequencing reveals new insights into tuberous sclerosis complex","volume":"12","author":"Duan","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"R73-20261014","doi-asserted-by":"crossref","first-page":"4899372","DOI":"10.1155\/2023\/4899372","article-title":"Targeted genomic sequencing of TSC1 and TSC2 reveals causal variants in individuals for whom previous genetic testing for tuberous sclerosis complex was normal","volume":"2023","author":"West","year":"2023","journal-title":"Hum Mutat"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:00:25Z","timestamp":1791961225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":72,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002608","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}